Have your say: A Clinician’s Perspective on the Role of Gastric Cancer Patient-Derived Organoids in Precision Medicine

We’re inviting clinicians to take part in a short 5-minute survey and share their insights on the use of patient-derived organoids to personalise chemotherapy for patients with non-curative gastric adenocarcinoma. Your insights will help guide future research and assess how this emerging technology could be integrated into clinical practice.

• Open to oncologists, surgeons, gastroenterologists, radiation oncologists, trainees, and other cancer care professionals

• Optional: Add your name/email to be acknowledged as part of the Gastric Cancer Organoid Survey Group and receive authorship on resulting publications

Click here to take the survey: https://redcap.link/GastricCancerOrganoidSurvey